Found 549753 clinical trials
Sort by:
Definitive Radiation Therapy for Inoperable Breast Cancer
Not Applicable
Not yet recruiting
- Conditions
- Breast CancerBreast Adenocarcinoma
- First Posted Date
- 2025-08-14
- Last Posted Date
- 2025-08-14
- Lead Sponsor
- Alexander Stessin
- Target Recruit Count
- 30
- Registration Number
- NCT07122713
- Locations
- 🇺🇸
Stony Brook University Cancer Center, Stony Brook, New York, United States
Additional Effects of Proprioceptive Neuromuscular Facilitation With Otago Exercises on Fall Risk in Diabetes Mellitus Patients
Not Applicable
Recruiting
- Conditions
- Postural BalanceDiabetes (DM)Fear of FallingSensory FunctionFall RiskDiabetic Neuropathy PeripheralProprioceptive Neuromuscular Facilitation
- First Posted Date
- 2025-08-14
- Last Posted Date
- 2025-08-14
- Lead Sponsor
- Foundation University Islamabad
- Target Recruit Count
- 30
- Registration Number
- NCT07122726
- Locations
- 🇵🇰
Foundation University College of Physical Therapy, Islamabad, Pakistan
Safety & Efficacy of RenalGuard® Therapy in the Prevention of Cardiac Surgery Associated Acute Kidney Injury
Not Applicable
Not yet recruiting
- Conditions
- Cardiac Surgery Associated - Acute Kidney InjuryAKI - Acute Kidney Injury
- First Posted Date
- 2025-08-14
- Last Posted Date
- 2025-08-14
- Lead Sponsor
- CardioRenal Systems, Inc.
- Target Recruit Count
- 300
- Registration Number
- NCT07123935
- Locations
- 🇲🇾
Institut Jantung Negara, Kuala Lumpur, Malaysia
🇲🇾Universiti Malaya Medical Centre, Kuala Lumpur, Malaysia
Diagnostic Value of Tc-99mMDP Bone Scan in Assessment of Renal Functions in Cancer Patients Compared to Estimated Glomerular Filtration Rate.
Not yet recruiting
- Conditions
- Cancer Patients Treated by Nephrotoxic Chemotherapy
- First Posted Date
- 2025-08-14
- Last Posted Date
- 2025-08-14
- Lead Sponsor
- Assiut University
- Target Recruit Count
- 40
- Registration Number
- NCT07123688
Implementation and Evaluation of an Internet-Based Stress Management Program for Health Students in the Sfax Region
Not Applicable
Not yet recruiting
- Conditions
- Anxiety Depression (Mild or Not Persistent)
- First Posted Date
- 2025-08-14
- Last Posted Date
- 2025-08-14
- Lead Sponsor
- University of Sfax
- Target Recruit Count
- 120
- Registration Number
- NCT07123311
- Locations
- 🇹🇳
Faculties of Sealth Sciences, Sfax, Tunisia
"Sleep Patterns and EEG Structure in Youth With Autism: Links With Behavior and Parental Stress"
Active, not recruiting
- Conditions
- Sleep Disorder (Disorder)Autism Spectrum Disorder
- First Posted Date
- 2025-08-14
- Last Posted Date
- 2025-08-14
- Lead Sponsor
- University of Campania Luigi Vanvitelli
- Target Recruit Count
- 187
- Registration Number
- NCT07122388
- Locations
- 🇮🇹
University of Campania Luigi Vanvitelli, Napoli, Italy
Predictive Factors for Initial MMSE Score and Rapid Decline in Alzheimer's Disease Patients
Not yet recruiting
- Conditions
- Alzheimer DiseaseMini-Mental State ExaminationCognitive DysfunctionNeuropsychological TestsCaregivers
- First Posted Date
- 2025-08-14
- Last Posted Date
- 2025-08-14
- Lead Sponsor
- Centre Hospitalier de Gonesse
- Target Recruit Count
- 100
- Registration Number
- NCT07122856
- Locations
- 🇫🇷
Centre Hospitalier de Gonesse, Gonesse, France
Outcomes After Total Elbow Arthroplasty
Completed
- Conditions
- Elbow Disease
- First Posted Date
- 2025-08-14
- Last Posted Date
- 2025-08-14
- Target Recruit Count
- 27
- Registration Number
- NCT07122570
- Locations
- 🇬🇧
Wrightington, Wigan & Leigh Teaching Hospitals NHS Foundation Trust, Wigan, United Kingdom
An Innovative Cognitive-Behavioral Treatment For Chronic Orofacial Pain
Not Applicable
Not yet recruiting
- Conditions
- Chronic Primary Orofacial Pain (CPOP)Persistent Idiopathic Facial Pain (PIFP)
- First Posted Date
- 2025-08-14
- Last Posted Date
- 2025-08-14
- Lead Sponsor
- Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
- Target Recruit Count
- 60
- Registration Number
- NCT07123233
- Locations
- 🇮🇹
Fondazione IRCCS Istituto Neurologico Carlo Besta, Milano, Italy
A Phase 1 Study of APX-343A as Monotherapy or in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors
Not Applicable
Not yet recruiting
- Conditions
- Advanced Solid CancerAdvanced Solid Tumor (Phase 1)
- Interventions
- Drug: APX-343A
- First Posted Date
- 2025-08-14
- Last Posted Date
- 2025-08-14
- Lead Sponsor
- Aptabio Therapeutics, Inc.
- Target Recruit Count
- 110
- Registration Number
- NCT07123415